Inventor
ROBBINS JOHN B
US38 patents
⚠️ This page may combine multiple inventors who share the name “ROBBINS JOHN B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
24 patentsUS6207157B1Mar 27, 2001
Conjugate vaccine for nontypeable Haemophilus influenzae
US HEALTH164 citations97
US5445817AAug 29, 1995
Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
US HEALTH66 citations92
US5204098AApr 20, 1993
Polysaccharide-protein conjugates
US HEALTH72 citations92
US7261900B2Aug 28, 2007
Recombinant modified Bacillus anthracis protective antigen for use in vaccines
US HEALTH15 citations91
US7247307B2Jul 24, 2007
Vaccines against Escherichia coli O157 infection
US HEALTH12 citations91
US6858211B1Feb 22, 2005
Vaccines against Escherichia coli O157 infection
US HEALTH26 citations91
US6797275B1Sep 28, 2004
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
US HEALTH15 citations91
US6685949B1Feb 3, 2004
Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans
US HEALTH26 citations91
US6632437B1Oct 14, 2003
Immunogenic polysaccharide-protein conjugates containing poly α(2→8), α(2→9) NeuNAc capsular polysaccharides
US HEALTH47 citations89
US9096653B2Aug 4, 2015
Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia
US HEALTH8 citations80
US7553490B2Jun 30, 2009
Vaccines against Escherichia coli O157 infection
US HEALTH7 citations72
US6607725B2Aug 19, 2003
Conjugate vaccine for nontypeable Haemophilus influenzae
US HEALTH10 citations72
US7422755B2Sep 9, 2008
Antimultiorganism glycoconjugate vaccine
US HEALTH3 citations62
US8044189B2Oct 25, 2011
Bacillus anthracis protective antigen nucleic acid sequences
US HEALTH1 citations61
US7754227B2Jul 13, 2010
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
US HEALTH2 citations61
US7527797B1May 5, 2009
Vibrio cholerae 0139 conjugate vaccines
US HEALTH3 citations61
US7803386B2Sep 28, 2010
Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli
US HEALTH5 citations59
US8383133B2Feb 26, 2013
Conjugates of Plasmodium falciparum surface proteins as malaria vaccines
US HEALTH2 citations58
US7763451B2Jul 27, 2010
Methods for preparing Bacillus anthracis protective antigen for use in vaccines
US HEALTH2 citations58
US8926986B2Jan 6, 2015
Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax
US HEALTH0 citations51
US9144604B2Sep 29, 2015
Vaccine for Shigella
US HEALTH0 citations50
US8900599B2Dec 2, 2014
Conjugates of Plasmodium falciparum surface proteins as malaria vaccines
US HEALTH0 citations50
US7625736B2Dec 1, 2009
Methods for preparing immunogenic conjugates
US HEALTH0 citations50
US7666846B2Feb 23, 2010
Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi
US HEALTH0 citations48